India's Ranbaxy hits record high before amalgamation with Sun Pharma
Wednesday, April 01, 2015
Ranbaxy Laboratories Ltd rises as much as 5.1 pct to hit an all-time high
Trading in Ranbaxy shares will be suspended from April 6 due to amalgamation with Sun Pharma Industries - NSE
Sun Pharmaceutical gains 4.3 pct
Morgan Stanley says Sun Pharma is preparing for the transition to the next level - speciality business
Says generic Nexium and hydroxychloroquine by Ranbaxy and Elepsia and Latanoprost drug by Sun Pharma unit Sun Pharma Advanced Research Co may provide good upside
The investment bank maintains Sun Pharma among its best ideas and raises target to 1,241 rupees from 995
in.reuters.com
